Medical Image Analysis Software Market

Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027

Report Code: HIT 1309 Jun, 2022, by marketsandmarkets.com

[361 Pages Report] The global medical image analysis software market is projected to reach USD 4.5 Billion by 2027 from USD 3.2 Billion in 2022, at a CAGR of 7.8%.

The market is mainly driven by factors such as the growing applications of computer-aided diagnosis, and other technological advancements in medical image analysis software. On the contrary, budgetary restraints are factors expected to restrain the market growth to a certain extent.

In this report, the medical image analysis software market is classified into six segments— type, image type, modality, application, end user, and region.

Medical Image Analysis Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact

The COVID-19 pandemic has upended many lives and businesses on an unprecedented scale. However, the healthcare IT industry, including the medical image analysis sector, has seen rapid technological advancements due to this adversity. According to Worldometer, there were 529,850,544 confirmed COVID-19 cases and 6,306,519 deaths recorded globally as of May 26, 2022. While many organizations found it difficult to run smoothly, the companies that opted for updating their technological infrastructure are functioning well.

According to a recent research study, 90% of the imaging centers in the US, and Western European countries experienced a significant decline in the volume of imaging tests (CT, X-Ray, MRI, and ultrasound) during this pandemic. While a few industries registered a demand drop, numerous other markets continued to remain unscathed and showed promising growth opportunities. Due to the rising prevalence of COVID-19, relative niche applications of medical imaging software in which lung scans have been done are expected to gain demand. However, as elective surgeries began taking place again post-COVID, these numbers also started increasing. A change in attitude and acceptance of AI in medical imaging has been observed post-pandemic. Numerous vendors have FDA-cleared or 510(k)-pending AI products that can offer a preliminary diagnosis.

Some countries promoted medical image analysis software in times of COVID-19 to make the process of providing timely care more efficient. For instance, in April, for the duration of the public health emergency declared by the secretary of Health and Human Services (HHS) on January 31, 2020, the US Food and Drug Administration (FDA) issued guidance to provide a policy to help expand the availability and capability of medical X-ray, ultrasound, and magnetic resonance imaging (MRI) systems, and image analysis software used to diagnose and monitor medical conditions.

Medical image analysis software reduces the burden on hospitals experiencing high numbers of COVID-19 patients by making radiology workflow smoother and more efficient. The pandemic led to major resource constraints. This resulted in the development of alternate pricing models and value-based pricing.

Medical image analysis software  Market Dynamics

Drivers: Technological advancements in medical imaging systems and analysis software

Medical imaging has transformed patient care by improving diagnosis and treatment and avoiding unnecessary procedures. Over the last decade, significant technological advancements have taken place in the field of medical imaging. Initially, X-ray was the majorly used diagnostic imaging modality; however, energy sources such as ultrasound and electromagnetic fields are increasingly being used for diagnosis and treatment planning for various medical indications.

In order to leverage growth opportunities and gain a competitive edge in the market, both established as well as new market players are focusing on developing and launching innovative tools and techniques in the market. Mentioned below are some of the important developments in this regard:

  • In March 2022, Coinlike Philips N.V. launched cloud-enabled enterprise imaging informatics and analytics solutions, HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge, which are fully integrated cloud-enabled Health IT platforms to meet diverse workflow needs across the imaging enterprise.
  • In November 2021, GE Healthcare (US) unveiled around 60 innovative technology solutions spanning the healthcare spectrum, including Enterprise Imaging in the Cloud.
  • In March 2021, Siemens Healthineers (Germany) launched Mammography imaging solutions, Mammovista B.smart and Teamplay Mammo Dashboard.

With the launch of such advanced offerings, the demand for medical image analysis software is expected to increase among end users in the coming years.

Restraints: Budgetary constraints

The high cost of imaging equipment, coupled with the high implementation and licensing cost of software, is the major factor restraining market growth, specifically in countries where the reimbursement scenario is poor. For instance, most healthcare facilities, such as hospitals and diagnostic centers, in developing countries cannot afford these systems due to their high installation and maintenance costs. For instance, the commercial pricing options for the first license of one of the companies providing image analysis software are as follows:

  • Node-locked: USD 10,602
  • Dongle: USD 10,974
  • Floating: USD 11,718

Due to the high cost of these systems and low financial resources, healthcare facilities in emerging countries are reluctant to invest in new or technologically advanced systems. Also, the implementation and subscription/licensing fees for advanced imaging tools are a major financial burden on end users. These factors can slow down digitalization in healthcare facilities and impact the adoption of advanced technologies for diagnosis and analysis.

Changing regulations and the COVID-19 pandemic are some of the major factors that have impacted hospital budgets in several regions, especially developing countries. Moreover, due to budget cuts, healthcare providers are finding it difficult to afford costly imaging modalities and analysis solutions. This, in turn, is expected to impact the growth of the medical image analysis software market.

Opportunities: Cloud-based image analysis solutions

The cloud-based solutions are coming up as effective media to deliver image analysis software. This provides an advantage of enhanced data accessibility and real-time analysis. These solutions aid in delivering analytical inputs from a large database without the constraints of location, time, or platform. The real-time updation of data is one of the biggest pros for cloud-based solutions.

Furthermore, capital investment on hardware is not required beforehand, which lowers the pressure on healthcare systems. In addition to this, along with rapid data transfers, these solutions decrease the involvement of IT staff in healthcare organisations. Therefore, the demand for cloud-based solutions is expected to increase in the coming years.

Several major players are taking to strategic initiatives to launch new products and expand their presence in the cloud-based medical image analysis software market. For instance, in November 2021, GE Healthcare (US) unveiled around 60 innovative technology solutions spanning the healthcare spectrum, including Enterprise Imaging in the Cloud. GE Healthcare also collaborated with Amazon Web Services (US) to deliver AI and cloud-based imaging solutions, integrated data, and clinical and operational insights to hospitals and healthcare providers. Additionally, in March 2022, Koninklijke Philips (Netherlands) launched HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge, which are Cloud-enabled enterprise imaging informatics and analytics solutions, to meet diverse workflow needs across the imaging enterprise. In August 2019, the company also acquired Carestream Health’s Healthcare Information Systems (HCIS) business, which includes its cloud-enabled enterprise imaging platform.

Challenges: Market penetration of standalone software vendors

Standalone/independent software developers are facing significant challenges in terms of market penetration owing to the strong presence of integrated modality manufacturers/OEMs and players that offer visualization, reconstruction, and analysis solutions along with imaging equipment. Integrated software providers include major players such as GE Healthcare (US), Philips Healthcare (Netherlands), and Siemens Healthineers (Germany). These players have well-established distribution channels and significant financial strength to support research and development activities. In this scenario, it is a challenging task for standalone vendors to influence the buying decision of end users and generate sales. Another challenge faced by standalone vendors is the complexity of processing; also, segmenting of images necessitates the training of radiologists. Moreover, highly skilled radiologists are required to preprocess images and ensure that no vital information is lost during segmentation. This requires additional staff and an extra outlay for training, which cannot be provided by smaller vendors.

“In 2021, the integrated software segment accounted for the largest market share.”

The integrated software segment is expected to grow in the forecast period due to the increase in adoption of diagnostic imaging, and the several benefits of integrated software, including centralized data storage and cost-effectiveness.  

“The cardiology segment accounted for the largest market share in 2021.”

In 2021, the cardiology segment was the largest segment of the medical image analysis software market. The large share of this segment can primarily be attributed to factors such as increasing innovations in cardiac imaging technologies, increasing adoption of MRI & CT scanners for cardiac imaging procedures, and the growing number of cardiac imaging tests due to the rising incidence of cardiac disorders.

“Asia Pacific was the fastest growing regional market for medical image analysis software market in 2021“

In 2021, North America accounted for the largest share of the market. Factors like presence of key market players, and high incidence/prevalence of various diseases contribute to the growth of this region.

Additionally, the fastest growing region in the medical image analysis software market is the Asia Pacific with a CAGR of 9.2% during the forecast period. This growth is driven by factors such as the growing medical imaging research, and the rising geriatric population .

Medical Image Analysis Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Key players offering medical image analysis software products in this market include GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Inc. (Japan), Agfa HealthCare (Belgium), International Business Machines Corporation (US), Carestream Health, Inc. (US), AQUILAB SAS (France), Esaote S.p.A. (Italy), MIM Software, Inc. (US), Image Analysis, Ltd. (UK), and ScienceSoft USA Corporation (US).

These companies adopted strategies such as service launches, business expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their presence in the medical image analysis software market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

:

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD)

Segments covered

Type, image type, modality, application, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America and Middle East & Africa

Companies covered

  • GE Healthcare (US)
  • Koninklijke Philips N.V. (Netherlands)
  • Siemens Healthineers  (Germany)
  • Canon Inc. (Japan)
  • Agfa HealthCare (Belgium)
  • IBM Corporation (US)
  • Carestream Health, Inc. (US)
  • AQUILAB SAS (France)
  • Esaote S.p.A. (Italy)
  • MIM Software, Inc. (US)
  • Image Analysis, Ltd. (UK)
  • ScienceSoft USA Corporation (US)
  • Xinapse Systems, Ltd. (Netherlands)
  • INFINITT Healthcare Co., Ltd. (China)
  • Dentsply Sirona (US)
  • Medis Medical Imaging Systems BV (Netherlands)
  • Neusoft Medical Systems Co., Ltd. (China)
  • Planmeca Oy (Finland)
  • AnalyzeDirect, Inc. (US)
  • Arterys, Inc. (US)
  • Media Cybernetics (US)
  • QMENTA US)
  • Cefla Medical Equipment (Italy)
  • Ziosoft (US)
  • Kitware, Inc. (US)
  • Lunit (South Korea)

The research report categorizes the medical image analysis software market into the following segments and subsegments:

Type

  • Integrated Software
  • Standalone Software

Image Type

  • 2D imaging
  • 3D imaging
  • 4D imaging

Modality

  • Tomography
    • Computed Tomography
      • High-end slice CT
      • Mid-end slice CT
      • Low-end slice CT
    • Magnetic Resonance Imaging
      • Closed MRI
      • Open MRI
    • Positron Emission Tomography
    • Single-photon Emission Computed Tomography
  • Radiographic Imaging
  • Ultasound Imaging
    • 2D Ultrasound Systems
    • 3D & 4D Ultrasound Systems
    • Doppler Imaging
  • Mammography
  • Combined Modalities
    • PET/MR
    • SPECT/CT
    • PET/MR

Application

  • Cardiology
  • Orthopedics
  • Oncology
  • Neurology
  • Obstetrics and Gynaecology
  • Mammography
  • Dental
  • Respiratory
  • Urology & Nephrology

End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Users

Region

  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In March 2022, Koninklijke Philips N.V. (Netherlands) launched Cloud-enabled Enterprise Imaging Informatics and Analytics Solutions, namely, HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge, to meet diverse workflow needs across the imaging enterprise.
  • In February 2022, IBM (US) acquired Neudesic, LLC (US) which was aimed at expanding IBM’s portfolio of hybrid multi-cloud services and further advancing the company’s hybrid cloud and AI strategy.
  • In February 2022, Siemens Healthineers (Germany) collaborated with Universal Medical Imaging (US) to help primary healthcare institutions in China improve the efficiency of their image screening and disease diagnosis using advanced imaging diagnostic equipment and remote scanning assistant tools from Siemens Healthineers and nationwide medical imaging experts at Universal Medical Imaging.
  • In January 2022, IBM (US) acquired ENVIZI (Australia) which was aimed at building on IBM's growing investments in AI-powered software.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 37)
    2.1 RESEARCH APPROACH
    2.2 RESEARCH METHODOLOGY DESIGN
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
    2.3 MARKET SIZE ESTIMATION: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.5 MARKET SHARE ESTIMATION
    2.6 ASSUMPTIONS FOR THE STUDY
    2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 50)

4 PREMIUM INSIGHTS (Page No. - 57)
    4.1 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET OVERVIEW
    4.2 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
    4.3 NORTH AMERICA: MARKET, BY TYPE AND COUNTRY (2021)
    4.4 ASIA PACIFIC: MARKET, BY MODALITY AND COUNTRY (2021)
    4.5 REGIONAL MIX: MARKET (2022–2027)
    4.6 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW (Page No. - 62)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Technological advancements in medical imaging systems and analysis software
                    5.2.1.2 Growing public- and private-sector investments in medical imaging market
                    5.2.1.3 Rising prevalence of chronic diseases
                    5.2.1.4 Growing applications of computer-aided diagnosis
           5.2.2 RESTRAINTS
                    5.2.2.1 Budgetary constraints
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Cloud-based image analysis solutions
                    5.2.3.2 Untapped emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Market penetration of standalone software vendors
                    5.2.4.2 Software security and compliance issues
                    5.2.4.3 Shortage of radiologists
    5.3 KEY CONFERENCES & EVENTS IN 2022–2023
    5.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

6 INDUSTRY INSIGHTS (Page No. - 78)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 ADOPTION OF HYBRID MEDICAL IMAGING MODALITIES
           6.2.2 SHIFT TO 3D IMAGING
           6.2.3 CLOUD COMPUTING
           6.2.4 ARTIFICIAL INTELLIGENCE (AI)
    6.3 TECHNOLOGY TRENDS
           6.3.1 MACHINE LEARNING, ARTIFICIAL INTELLIGENCE, AND COMPUTER-AIDED DESIGN IN MEDICAL IMAGE ANALYSIS
    6.4 SUPPLY CHAIN ANALYSIS
    6.5 ECOSYSTEM MAPPING
    6.6 PORTER’S FIVE FORCES ANALYSIS
           6.6.1 THREAT OF NEW ENTRANTS
                    6.6.1.1 Capital requirement
                    6.6.1.2 High preference for products from well-established brands
           6.6.2 THREAT OF SUBSTITUTES
                    6.6.2.1 Substitutes for medical image analysis software
           6.6.3 BARGAINING POWER OF SUPPLIERS
                    6.6.3.1 Presence of several raw material suppliers
                    6.6.3.2 Supplier switching costs
           6.6.4 BARGAINING POWER OF BUYERS
                    6.6.4.1 Few companies offer premium products at global level
           6.6.5 INTENSITY OF COMPETITIVE RIVALRY
                    6.6.5.1 Increasing demand for high-quality and innovative products
                    6.6.5.2 Lucrative growth potential in emerging markets
    6.7 PATENT ANALYSIS
           6.7.1 PATENT PUBLICATION TRENDS FOR MEDICAL IMAGE ANALYSIS SOFTWARE
           6.7.2 TOP APPLICANTS (COMPANIES) FOR MEDICAL IMAGE ANALYSIS SOFTWARE PATENTS
           6.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
    6.8 REGULATORY ANALYSIS
           6.8.1 NORTH AMERICA
           6.8.2 EUROPE
           6.8.3 ASIA PACIFIC
           6.8.4 MIDDLE EAST & AFRICA
           6.8.5 LATIN AMERICA
    6.9 PRICING ANALYSIS
    6.10 TRADE ANALYSIS
           6.10.1 TRADE ANALYSIS FOR COMPUTED TOMOGRAPHY SYSTEMS
           6.10.2 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS
           6.10.3 TRADE ANALYSIS FOR MAGNETIC RESONANCE IMAGING SYSTEMS
           6.10.4 TRADE ANALYSIS FOR X-RAY SYSTEMS
    6.11 IMPACT OF COVID-19 ON MEDICAL IMAGE ANALYSIS SOFTWARE MARKET

7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE (Page No. - 96)
    7.1 INTRODUCTION
    7.2 INTEGRATED SOFTWARE
           7.2.1 INTEGRATED SOFTWARE IS LARGEST & FASTEST-GROWING SEGMENT OF MARKET
    7.3 STANDALONE SOFTWARE
           7.3.1 STANDALONE SOFTWARE OFFERS HIGHER FLEXIBILITY WITH NUMEROUS FEATURES

8 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE (Page No. - 103)
    8.1 INTRODUCTION
    8.2 3D IMAGING
           8.2.1 GROWING ACCEPTANCE AND RISING ADVANTAGES OF THIS TECHNIQUE ARE SUPPORTING MARKET GROWTH
    8.3 4D IMAGING
           8.3.1 4D MEDICAL IMAGING IS REPLACING TRADITIONAL SURGICAL INTERVENTIONS BY PROVIDING MINIMALLY INVASIVE ALTERNATIVES
    8.4 2D IMAGING
           8.4.1 2D IMAGING IS COST-EFFECTIVE, SIMPLER, FASTER, AND EASIER TO PERFORM

9 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY (Page No. - 111)
    9.1 INTRODUCTION
    9.2 TOMOGRAPHY
           9.2.1 COMPUTED TOMOGRAPHY (CT)
                    9.2.1.1 High-end slice CT
                               9.2.1.1.1 Increasing R&D investments by market players to drive market growth
                    9.2.1.2 Mid-end slice CT
                               9.2.1.2.1 Uncertain reimbursements and insurance coverage in developing countries to restrain market growth
                    9.2.1.3 Low-end slice CT
                               9.2.1.3.1 Low cost and significant demand in emerging markets will drive market
           9.2.2 MAGNETIC RESONANCE IMAGING (MRI)
                    9.2.2.1 Closed MRI systems
                               9.2.2.1.1 Increasing prevalence of brain-related disorders/diseases is propelling market growth
                    9.2.2.2 Open MRI systems
                               9.2.2.2.1 Open MRI systems work on same principle as traditional MRI systems
           9.2.3 POSITRON EMISSION TOMOGRAPHY (PET)
                    9.2.3.1 There has been shift from standalone PET scans to combined modalities like PET/CT and PET/MR
           9.2.4 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)
                    9.2.4.1 Growing prevalence of chronic neurological disorders will increase usage of SPECT scans
    9.3 ULTRASOUND IMAGING
           9.3.1 2D ULTRASOUND SYSTEMS
                    9.3.1.1 Higher resolution of 2D imaging systems to increase their adoption
           9.3.2 3D AND 4D ULTRASOUND SYSTEMS
                    9.3.2.1 Growing number of new products launches with technological and software modifications are propelling market growth
           9.3.3 DOPPLER IMAGING
                    9.3.3.1 Technological developments by market players in Doppler imaging to aid market growth
    9.4 RADIOGRAPHIC IMAGING
           9.4.1 INCREASED ADOPTION OF RADIOGRAPHIC IMAGING TECHNIQUES DUE TO COVID-19 PANDEMIC TO DRIVE MARKET
    9.5 COMBINED MODALITIES
           9.5.1 PET/CT
                    9.5.1.1 PET/CT is more powerful than standalone PET systems
           9.5.2 SPECT/CT
                    9.5.2.1 Growing number of new product launches to drive market
           9.5.3 PET/MR
                    9.5.3.1 PET/MR is more effective than PET/CT as it offers less radiation exposure and higher contrast
    9.6 MAMMOGRAPHY
           9.6.1 INCREASING INCIDENCE OF BREAST CANCER TO DRIVE MARKET

10 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION (Page No. - 148)
     10.1 INTRODUCTION
     10.2 CARDIOLOGY
             10.2.1 RISING INCIDENCE OF CARDIAC DISORDERS TO DRIVE MARKET
     10.3 ORTHOPEDICS
             10.3.1 RISING ARTHRITIS CASES ARE SUPPORTING MARKET GROWTH
     10.4 ONCOLOGY
             10.4.1 GROWING NUMBER OF CANCER CASES TO DRIVE MARKET
     10.5 NEUROLOGY
             10.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES IS DRIVING GROWTH OF THIS SEGMENT
     10.6 OBSTETRICS AND GYNECOLOGY
             10.6.1 MRI IS WIDELY USED IMAGING TECHNIQUE IN OBSTETRICS AND GYNECOLOGY
     10.7 MAMMOGRAPHY
             10.7.1 INCREASING DEMAND FOR EFFICIENCY IN BREAST IMAGING TO DRIVE MARKET
     10.8 DENTAL
             10.8.1 INCREASING PREVALENCE OF OROPHARYNGEAL CANCER TO SUPPORT MARKET GROWTH
     10.9 RESPIRATORY
             10.9.1 COVID-19 PANDEMIC HAS INCREASED DEMAND FOR X-RAY IMAGING
     10.10 UROLOGY AND NEPHROLOGY
             10.10.1 RISING INCIDENCE OF KIDNEY DISEASE IS DRIVING UROLOGY AND NEPHROLOGY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
     10.11 VASCULAR
             10.11.1 RISING INCIDENCE OF VASCULAR DISORDERS TO PROPEL MARKET GROWTH

11 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER (Page No. - 169)
     11.1 INTRODUCTION
     11.2 HOSPITALS
             11.2.1 HIGH ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE MARKET
     11.3 DIAGNOSTIC IMAGING CENTERS
             11.3.1 LOWER WAITING PERIODS IN DIAGNOSTIC IMAGING CENTERS AND QUICKER RESULTS ARE SUPPORTING GROWTH OF THIS SEGMENT
     11.4 OTHER END USERS

12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION (Page No. - 176)
     12.1 INTRODUCTION
     12.2 NORTH AMERICA
             12.2.1 US
                        12.2.1.1 Growth of medical technologies industry to support market growth
             12.2.2 CANADA
                        12.2.2.1 Growing investments in medical imaging field to drive market
     12.3 EUROPE
             12.3.1 GERMANY
                        12.3.1.1 High adoption of diagnostic imaging systems and strong healthcare infrastructure to drive market in Germany
             12.3.2 FRANCE
                        12.3.2.1 Growing public-private investments and rising number of imaging centers to support market growth
             12.3.3 UK
                        12.3.3.1 Rising demand for medical imaging procedures to support market growth
             12.3.4 SPAIN
                        12.3.4.1 Favorable regulatory scenario and rising geriatric population are key growth drivers
             12.3.5 ITALY
                        12.3.5.1 Well-established healthcare infrastructure to support overall market growth
             12.3.6 REST OF EUROPE
     12.4 ASIA PACIFIC
             12.4.1 JAPAN
                        12.4.1.1 Technological advancements to aid market growth
             12.4.2 CHINA
                        12.4.2.1 Strong government support for healthcare reforms and increasing number of medical imaging procedures to drive market
             12.4.3 INDIA
                        12.4.3.1 Improving healthcare infrastructure to support growth of medical image analysis software market in India
             12.4.4 REST OF ASIA PACIFIC
     12.5 LATIN AMERICA
             12.5.1 BRAZIL
                        12.5.1.1 Growing disease burden and rising awareness to drive market for medical image analysis software
             12.5.2 MEXICO
                        12.5.2.1 Government initiatives to boost adoption of medical image analysis software solutions
             12.5.3 REST OF LATIN AMERICA
     12.6 MIDDLE EAST & AFRICA
             12.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE SYSTEMS TO BOOST MARKET GROWTH

13 COMPETITIVE LANDSCAPE (Page No. - 279)
     13.1 OVERVIEW
     13.2 KEY PLAYER STRATEGIES/RIGHT-TO-WIN
             13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
     13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
     13.4 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS
     13.5 COMPANY EVALUATION QUADRANT
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
     13.6 START-UP/SME EVALUATION QUADRANT
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 DYNAMIC COMPANIES
             13.6.3 STARTING BLOCKS
             13.6.4 RESPONSIVE COMPANIES
     13.7 KEY STAKEHOLDERS & BUYING CRITERIA
             13.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
             13.7.2 BUYING CRITERIA
     13.8 MARKET RANKING ANALYSIS
     13.9 COMPETITIVE SCENARIO
             13.9.1 PRODUCT LAUNCHES & APPROVALS
             13.9.2 DEALS

14 COMPANY PROFILES (Page No. - 299)
     14.1 KEY PLAYERS
             14.1.1 GE HEALTHCARE
                        14.1.1.1 Business overview
                        14.1.1.2 Products offered
                        14.1.1.3 Recent developments
                        14.1.1.4 MnM view
                                     14.1.1.4.1 Right to win
                                     14.1.1.4.2 Strategic choices
                                     14.1.1.4.3 Weaknesses and competitive threats
             14.1.2 KONINKLIJKE PHILIPS N.V.
                        14.1.2.1 Business overview
                        14.1.2.2 Products offered
                        14.1.2.3 Recent developments
                        14.1.2.4 MnM view
                                     14.1.2.4.1 Right to win
                                     14.1.2.4.2 Strategic choices
                                     14.1.2.4.3 Weaknesses and competitive threats
             14.1.3 SIEMENS HEALTHINEERS
                        14.1.3.1 Business overview
                        14.1.3.2 Products offered
                        14.1.3.3 Recent developments
                        14.1.3.4 MnM view
                                     14.1.3.4.1 Right to win
                                     14.1.3.4.2 Strategic choices
                                     14.1.3.4.3 Weaknesses and competitive threats
             14.1.4 CANON INC.
                        14.1.4.1 Business overview
                        14.1.4.2 Products offered
                        14.1.4.3 Recent developments
             14.1.5 AGFA HEALTHCARE (AGFA-GEVAERT GROUP)
                        14.1.5.1 Business overview
                        14.1.5.2 Products offered
                        14.1.5.3 Recent developments
                        14.1.5.4 MnM view
                                     14.1.5.4.1 Right to win
                                     14.1.5.4.2 Strategic choices
                                     14.1.5.4.3 Weaknesses and competitive threats
             14.1.6 INTERNATIONAL BUSINESS MACHINES (IBM) CORPORATION
                        14.1.6.1 Business overview
                        14.1.6.2 Products offered
                        14.1.6.3 Recent developments
                        14.1.6.4 MnM view
                                     14.1.6.4.1 Right to win
                                     14.1.6.4.2 Strategic choices
                                     14.1.6.4.3 Weaknesses and competitive threats
             14.1.7 CARESTREAM HEALTH
                        14.1.7.1 Business overview
                        14.1.7.2 Products offered
                        14.1.7.3 Recent developments
             14.1.8 AQUILAB SAS
                        14.1.8.1 Business overview
                        14.1.8.2 Products offered
                        14.1.8.3 Recent developments
             14.1.9 ESAOTE S.P.A.
                        14.1.9.1 Business overview
                        14.1.9.2 Products offered
                        14.1.9.3 Recent developments
             14.1.10 MIM SOFTWARE INC.
                        14.1.10.1 Business overview
                        14.1.10.2 Products offered
             14.1.11 IMAGE ANALYSIS, LTD.
                        14.1.11.1 Business overview
                        14.1.11.2 Products offered
                        14.1.11.3 Recent developments
             14.1.12 SCIENCESOFT USA CORPORATION
                        14.1.12.1 Business overview
                        14.1.12.2 Products offered
                        14.1.12.3 Recent developments
             14.1.13 XINAPSE SYSTEMS LTD
                        14.1.13.1 Business overview
                        14.1.13.2 Products offered
             14.1.14 INFINITT HEALTHCARE CO., LTD.
                        14.1.14.1 Business overview
                        14.1.14.2 Products offered
                        14.1.14.3 Recent developments
             14.1.15 DENTSPLY SIRONA
                        14.1.15.1 Business overview
                        14.1.15.2 Products offered
             14.1.16 MEDIS MEDICAL IMAGING SYSTEMS BV
                        14.1.16.1 Business overview
                        14.1.16.2 Products offered
                        14.1.16.3 Recent developments
             14.1.17 NEUSOFT MEDICAL SYSTEMS CO., LTD.
                        14.1.17.1 Business overview
                        14.1.17.2 Products offered
                        14.1.17.3 Recent developments
             14.1.18 PLANMECA OY
                        14.1.18.1 Business overview
                        14.1.18.2 Products offered
                        14.1.18.3 Recent developments
             14.1.19 ANALYZEDIRECT, INC.
                        14.1.19.1 Business overview
                        14.1.19.2 Products offered
             14.1.20 ARTERYS INC.
                        14.1.20.1 Business overview
                        14.1.20.2 Products offered
                        14.1.20.3 Recent developments
             14.1.21 MEDIA CYBERNETICS, INC.
                        14.1.21.1 Business overview
                        14.1.21.2 Products offered
                        14.1.21.3 Recent developments
     14.2 OTHER PLAYERS
             14.2.1 QMENTA
             14.2.2 CEFLA MEDICAL EQUIPMENT (CEFLA S.C.)
             14.2.3 ZIOSOFT
             14.2.4 KITWARE, INC.
             14.2.5 LUNIT INC.

15 APPENDIX (Page No. - 352)
     15.1 DISCUSSION GUIDE
     15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     15.3 AVAILABLE CUSTOMIZATIONS
     15.4 RELATED REPORTS
     15.5 AUTHOR DETAILS


LIST OF TABLES (342 TABLES)

TABLE 1 LIMITATIONS & ASSOCIATED RISKS
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN DIAGNOSTIC IMAGING MARKET
TABLE 3 INSTALLED BASE OF CT, MRI, AND PET-CT IN ASIAN COUNTRIES (2015)
TABLE 4 NUCLEAR MEDICINE INFRASTRUCTURE IN ASIAN AND MIDDLE EASTERN COUNTRIES (2015)
TABLE 5 LARGEST HEALTHCARE DATA BREACHES IN THE WORLD (2020-2021)
TABLE 6 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 13 COMMERCIAL PRICING (USD)
TABLE 14 ACADEMIC PRICING (USD)
TABLE 15 REGIONAL PRICING ANALYSIS OF KEY DIAGNOSTIC IMAGING MODALITIES, 2020 (USD)
TABLE 16 IMPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 17 EXPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 18 IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 19 EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 20 IMPORT DATA FOR MAGNETIC RESONANCE IMAGING SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 21 EXPORT DATA FOR MAGNETIC RESONANCE IMAGING SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 22 IMPORT DATA FOR X-RAY SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 23 EXPORT DATA FOR X-RAY SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 24 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 25 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 26 INTEGRATED MEDICAL IMAGE ANALYSIS SOFTWARE VENDORS
TABLE 27 INTEGRATED IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 STANDALONE MEDICAL IMAGE ANALYSIS SOFTWARE VENDORS
TABLE 29 STANDALONE IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 30 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 31 3D IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 32 3D IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 33 4D IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 34 4D IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 2D IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 36 2D IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 37 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 38 TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 39 TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 40 CT IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 41 COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 43 HIGH-END SLICE CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 44 MID-END SLICE CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 LOW-END SLICE CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 MAGNETIC RESONANCE IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 47 MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 48 MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 49 CLOSED MRI IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 OPEN MRI IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 PET IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 52 POSITRON EMISSION TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 SPECT IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 54 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 55 ULTRASOUND IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 56 ULTRASOUND IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 ULTRASOUND IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 58 ULTRASOUND 2D IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 ULTRASOUND 3D AND 4D IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 60 DOPPLER IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 61 RADIOGRAPHIC IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 62 RADIOGRAPHIC IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 63 COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 COMBINED MODALITY IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 65 PET/CT IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 66 PET/CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 SPECT/CT IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 68 SPECT/CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 69 PET/MR IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 70 PET/MR IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 71 MAMMOGRAPHY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 72 MAMMOGRAPHY IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 73 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 74 CARDIOLOGY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 75 MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 76 ORTHOPEDICS IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 77 MARKET FOR ORTHOPEDICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 78 ONCOLOGY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 79 MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 NEUROLOGY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 81 MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 82 MARKET FOR OBSTETRICS AND GYNECOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 83 MAMMOGRAPHY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 84 MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 85 DENTAL IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 86 MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 87 RESPIRATORY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 88 MARKET FOR RESPIRATORY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 89 UROLOGY AND NEPHROLOGY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 90 MARKET FOR UROLOGY AND NEPHROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 91 VASCULAR IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS
TABLE 92 MARKET FOR VASCULAR APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 93 MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 94 MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 95 MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 96 MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 97 MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 98 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 99 NORTH AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 NORTH AMERICA: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 101 NORTH AMERICA: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 102 NORTH AMERICA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 NORTH AMERICA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 NORTH AMERICA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 NORTH AMERICA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 NORTH AMERICA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 108 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 109 US: KEY MACROINDICATORS
TABLE 110 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 US: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 112 US: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 113 US: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 US: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 US: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 US: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 US: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 120 CANADA: KEY MACROINDICATORS
TABLE 121 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 CANADA: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 123 CANADA: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 124 CANADA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 CANADA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 CANADA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 CANADA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 CANADA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 130 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 131 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 132 EUROPE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 EUROPE: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 134 EUROPE: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 135 EUROPE: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 EUROPE: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 EUROPE: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 EUROPE: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 EUROPE: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 141 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 142 GERMANY: KEY MACROINDICATORS
TABLE 143 GERMANY: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 GERMANY: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 145 GERMANY: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 146 GERMANY: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 GERMANY: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 GERMANY: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 GERMANY: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 GERMANY: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 152 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 153 FRANCE: KEY MACROINDICATORS
TABLE 154 FRANCE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 FRANCE: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 156 FRANCE: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 157 FRANCE: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 FRANCE: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 FRANCE: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 FRANCE: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 FRANCE: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 163 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 164 UK: KEY MACROINDICATORS
TABLE 165 UK: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 UK: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 167 UK: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 168 UK: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 UK: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 UK: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 UK: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 UK: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 174 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 175 SPAIN: KEY MACROINDICATORS
TABLE 176 SPAIN: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 SPAIN: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 178 SPAIN: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 179 SPAIN: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 SPAIN: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 SPAIN: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 SPAIN: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 SPAIN: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 185 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 186 ITALY: KEY MACROINDICATORS
TABLE 187 ITALY: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 ITALY: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 189 ITALY: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 190 ITALY: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 ITALY: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 ITALY: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 ITALY: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 ITALY: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 196 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 197 ROE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 ROE: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 199 ROE: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 200 ROE: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 ROE: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 ROE: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 203 ROE: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 ROE: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 ROE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 206 ROE: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 207 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 208 ASIA PACIFIC: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 209 ASIA PACIFIC: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 210 ASIA PACIFIC: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 211 ASIA PACIFIC: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 ASIA PACIFIC: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 ASIA PACIFIC: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 ASIA PACIFIC: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 ASIA PACIFIC: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 216 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 217 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 218 JAPAN: KEY MACROINDICATORS
TABLE 219 JAPAN: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 JAPAN: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 221 JAPAN: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 222 JAPAN: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 223 JAPAN: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 224 JAPAN: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 225 JAPAN: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 226 JAPAN: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 227 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 228 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 229 CHINA: KEY MACROINDICATORS
TABLE 230 CHINA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 231 CHINA: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 232 CHINA: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 233 CHINA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 234 CHINA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 235 CHINA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 236 CHINA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 CHINA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 238 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 239 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 240 INDIA: KEY MACROINDICATORS
TABLE 241 INDIA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 242 INDIA: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 243 INDIA: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 244 INDIA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 245 INDIA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 246 INDIA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 247 INDIA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 248 INDIA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 249 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 250 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 251 ROAPAC: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 252 ROAPAC: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 253 ROAPAC: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 254 ROAPAC: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 255 ROAPAC: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 256 ROAPAC: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 257 ROAPAC: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 258 ROAPAC: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 259 ROAPAC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 260 ROAPAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 261 LATIN AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 262 LATIN AMERICA: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 263 LATIN AMERICA: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 264 LATIN AMERICA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 265 LATIN AMERICA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 266 LATIN AMERICA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 267 LATIN AMERICA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 268 LATIN AMERICA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 269 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 270 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 271 BRAZIL: KEY MACROINDICATORS
TABLE 272 BRAZIL: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 273 BRAZIL: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 274 BRAZIL: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 275 BRAZIL: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 276 BRAZIL: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 277 BRAZIL: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 278 BRAZIL: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 279 BRAZIL: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 280 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 281 BRAZIL: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 282 MEXICO: KEY MACROINDICATORS
TABLE 283 MEXICO: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 284 MEXICO: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 285 MEXICO: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 286 MEXICO: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 287 MEXICO: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 288 MEXICO: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 289 MEXICO: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 290 MEXICO: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 291 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 292 MEXICO: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 293 ROLATAM: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 294 ROLATAM: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 295 ROLATAM: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 296 ROLATAM: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 297 ROLATAM: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 298 ROLATAM: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 299 ROLATAM: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 300 ROLATAM: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 301 ROLATAM: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 302 ROLATAM: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 303 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 304 MIDDLE EAST & AFRICA: MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION)
TABLE 305 MIDDLE EAST & AFRICA: MARKET, BY MODALITY, 2020–2027 (USD MILLION)
TABLE 306 MIDDLE EAST & AFRICA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 307 MIDDLE EAST & AFRICA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 308 MIDDLE EAST & AFRICA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 309 MIDDLE EAST & AFRICA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 310 MIDDLE EAST & AFRICA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 311 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 312 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 313 OVERALL FOOTPRINT OF COMPANIES
TABLE 314 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES)
TABLE 315 END-USER FOOTPRINT OF COMPANIES (26 COMPANIES)
TABLE 316 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES)
TABLE 317 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 318 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MEDICAL IMAGE ANALYSIS SOFTWARE
TABLE 319 KEY BUYING CRITERIA FOR MEDICAL IMAGE ANALYSIS SOFTWARE
TABLE 320 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2018–MAY 2022
TABLE 321 DEALS, JANUARY 2018–MAY 2022
TABLE 322 GE HEALTHCARE: BUSINESS OVERVIEW
TABLE 323 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
TABLE 324 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
TABLE 325 CANON INC.: BUSINESS OVERVIEW
TABLE 326 AGFA HEALTHCARE (AGFA-GEVAERT GROUP): BUSINESS OVERVIEW
TABLE 327 IBM: BUSINESS OVERVIEW
TABLE 328 CARESTREAM HEALTH: BUSINESS OVERVIEW
TABLE 329 AQUILAB SAS: BUSINESS OVERVIEW
TABLE 330 ESAOTE S.P.A.: BUSINESS OVERVIEW
TABLE 331 MIM SOFTWARE INC.: BUSINESS OVERVIEW
TABLE 332 IMAGE ANALYSIS, LTD.: BUSINESS OVERVIEW
TABLE 333 SCIENCESOFT USA CORPORATION: BUSINESS OVERVIEW
TABLE 334 XINAPSE SYSTEMS LTD: BUSINESS OVERVIEW
TABLE 335 INFINITT HEALTHCARE CO. LTD.: BUSINESS OVERVIEW
TABLE 336 DENTSPLY SIRONA: BUSINESS OVERVIEW
TABLE 337 MEDIS MEDICAL IMAGING SYSTEMS BV: BUSINESS OVERVIEW
TABLE 338 NEUSOFT MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
TABLE 339 PLANMECA OY: BUSINESS OVERVIEW
TABLE 340 ANALYZEDIRECT, INC.: BUSINESS OVERVIEW
TABLE 341 ARTERYS, INC.: BUSINESS OVERVIEW
TABLE 342 MEDIA CYBERNETICS: BUSINESS OVERVIEW


LIST OF FIGURES (56 FIGURES)

FIGURE 1 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SEGMENTATION
FIGURE 2 MARKET: RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2021)
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2022–2027)
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 MARKET, BY IMAGE TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 MARKET, BY MODALITY, 2022 VS. 2027 (USD MILLION)
FIGURE 15 TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 17 COMBINED MODALITY IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 18 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 19 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF MARKET
FIGURE 21 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL IMAGING SYSTEMS AND ANALYSIS SOFTWARE TO DRIVE MARKET GROWTH
FIGURE 22 CHINA TO WITNESS HIGHEST GROWTH IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET DURING FORECAST PERIOD
FIGURE 23 INTEGRATED SOFTWARE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021
FIGURE 24 TOMOGRAPHY SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET IN 2021
FIGURE 25 ASIA PACIFIC REGION TO WITNESS HIGHEST GROWTH BETWEEN 2022 AND 2027
FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 27 MARKET DYNAMICS: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
FIGURE 28 PREVALENCE OF CHRONIC DISEASE-RELATED DEATHS IN DEVELOPED AND DEVELOPING COUNTRIES WORLDWIDE (2020)
FIGURE 29 NUMBER OF CT AND MRI SCANNERS PER MILLION POPULATION, BY COUNTRY (2019)
FIGURE 30 NUMBER OF DATA BREACHES IN THE US (2010–2020)
FIGURE 31 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: STAKEHOLDERS IN SUPPLY CHAIN
FIGURE 32 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: ECOSYSTEM ANALYSIS
FIGURE 33 GLOBAL PATENT PUBLICATION TRENDS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2018–2022
FIGURE 34 TOP COMPANIES THAT APPLIED FOR MEDICAL IMAGE ANALYSIS SOFTWARE PATENTS, 2018–2022
FIGURE 35 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL IMAGE ANALYSIS SOFTWARE PATENTS, 2018–2022
FIGURE 36 COMBINED PET SCANNERS PER MILLION POPULATION, BY COUNTRY (2019)
FIGURE 37 NUMBER OF HOSPITALS, BY COUNTRY (2019)
FIGURE 38 US: NUMBER OF AMBULATORY SURGERY CENTERS (2012–2022)
FIGURE 39 CHINA TO WITNESS HIGHEST GROWTH IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET DURING FORECAST PERIOD
FIGURE 40 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SNAPSHOT
FIGURE 41 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SNAPSHOT
FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
FIGURE 43 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
FIGURE 44 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUP COMPANIES (2021)
FIGURE 45 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MEDICAL IMAGE ANALYSIS SOFTWARE
FIGURE 46 KEY BUYING CRITERIA FOR MEDICAL IMAGE ANALYSIS SOFTWARE
FIGURE 47 LEADING PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2021)
FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2021)
FIGURE 49 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
FIGURE 50 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021)
FIGURE 51 CANON INC.: COMPANY SNAPSHOT (2021)
FIGURE 52 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2021)
FIGURE 53 IBM: COMPANY SNAPSHOT (2021)
FIGURE 54 ONEX CORPORATION: COMPANY SNAPSHOT (2021)
FIGURE 55 DENTSPLY SIRONA: COMPANY SNAPSHOT (2021)
FIGURE 56 NEUSOFT CORPORATION: COMPANY SNAPSHOT (2021)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Medical image analysis software market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the Medical image analysis software market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents is provided below:

Medical Image Analysis Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the Medical image analysis software market was arrived at after data triangulation from two different approaches, as mentioned below.

Approach to calculate the revenue of different players in the Medical image analysis software market

The size of the global Medical image analysis software market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global Medical image analysis software market was derived.

Approach to derive the market size and estimate market growth

The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Objectives of the Study

  • To define, describe, and forecast the global medical image analysis software market by type, image type, modality, application, end user, and region, in terms of value
  • To forecast the size of the global medical image analysis software market with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the market growth
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape
  • To profile key players in the global medical image analysis software market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as agreements, partnerships, collaborations, product/technology developments, and R&D activities of leading players in the global Medical image analysis software market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific medical image analysis software market into Singapore, Australia, South Korea, New Zealand, and other countries
  • Further breakdown of the Rest of Europe medical image analysis software market into Belgium, Russia, the Netherlands, Switzerland, and other countries
  • Further breakdown of the Rest of Latin America medical image analysis software market into the Argentina, Peru, Columbia, Ecuador, and other countries.
Medical Image Analysis Software Market Size,  Share & Growth Report
Report Code
HIT 1309
Published ON
Jun, 2022
Choose License Type
BUY NOW
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status